Unjha Formulations has informed that the meeting of the Board of Directors of the Company is scheduled on 02/05/2022, to consider and take on record Audited Financial Results of the company for the Quarter Ended on 31.03 .2022 and Year Ended on 31.03.2022 of the Financial Year 2021-22; to appointment of Statutory Auditors for FY 2022-23 to 2026-27; to appoint Secretarial Auditor's for the FY 2022-23; and any other matter as per per-view of Chairman.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.60 |
| Dr. Reddys Lab | 1232.65 |
| Cipla | 1242.10 |
| Zydus Lifesciences | 944.25 |
| Lupin | 2328.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: